ALLEGORY

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

ObinutuzumabOngoingActive not recruitingPhase 3Open NCT04963296 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

ALLEGORY · Trial Tracker · ComplyRx